Ultrasensitive microfluidic array for serum pro-inflammatory cytokines and C-reactive protein to assess oral mucositis risk in cancer patients

Analytical and Bioanalytical Chemistry

Volumn 407, Issue 23, 2015, Pages 7239-7243

  Krause, Colleen E ^a   Otieno, Brunah A ^a   Bishop, Gregory W ^a   Phadke, Gayatri ^a   Choquette, Linda ^b   Lalla, Rajesh V ^b   Peterson, Douglas E ^b   Rusling, James F ^a,b,c  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Antibodies; Cytokines; Immunoassay; Inflammatory; Microfluidic; Oral mucositis

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE;

BLOOD; DEVICE FAILURE ANALYSIS; DEVICES; EQUIPMENT DESIGN; HUMAN; IMMUNOMAGNETIC SEPARATION; LAB ON A CHIP; PROTEIN MICROARRAY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STOMATITIS;

BIOMARKERS; C-REACTIVE PROTEIN; CYTOKINES; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HUMANS; IMMUNOMAGNETIC SEPARATION; INFLAMMATION MEDIATORS; LAB-ON-A-CHIP DEVICES; PROTEIN ARRAY ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STOMATITIS;

EID: 84935126282     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-015-8873-1     Document Type: Note

References (11)

1. Sonis ST (2004) The pathobiology of mucositis. Nat Rev Cancer 4: 277-284
2. Logan RM, Gibson RJ, Bowen JM, Stringer AM, Sonis ST, Keefe DMK (2008) Characterisation ofmucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology ofmucositis. Cancer Chemother Pharmacol 62: 33-41
3. Peterson D, Srivastava R, Lalla R (2013) Oral mucosal injury in oncology patients: perspectives on maturation of a field. Oral Dis. doi: 10.1111/odi.12167
4. Morales-Rojas T, Viera N, Morón-Medina A, Alvarez CJ, Alvarez A (2012) Proinflammatory cytokines during the initial phase of oral mucositis in patients with acute lymphoblastic leukaemia. Int J Paediatr Dent 22: 191-196
5. Ki Y, Kim W, Nam J, Kim D, Park D, Kim D (2009) C-reactive protein levels and radiation-induced mucositis in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 75: 393-398
6. Mohammed FF, Poon I, Zhang L, Elliott L, Hodson ID, Sagar SM, Wright J (2012) Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer. Head Neck 34: 985-993
7. Chikkaveeraiah BV, Mani V, Patel V, Gutkind JS, Rusling JF (2011) Microfluidic electrochemical immunoarray for ultrasensitive detection of two cancer biomarker proteins in serum. Biosens Bioelectron 26: 4477-4483
8. Malhotra R, Patel V, Chikkaveeraiah BV, Munge BS, Cheong SC, Zain RB, Abraham MT, Dey DK, Gutkind JS, Rusling JF (2012) Ultrasensitive detection of cancer biomarkers in the clinic by use of a nanostructured microfluidic array. Anal Chem 84: 6249-6255
9. Otieno BA, Krause CE, Latus A, Chikkaveeraiah BV, Faria RC, Rusling JF (2014) On-line protein capture on magnetic beads for ultrasensitive microfluidic immunoassays of cancer biomarkers. Biosens Bioelectron 53: 268-274
10. Brailo V, Vucicevic-Boras V, Lukac J, Biocina-Lukenda D, Zilic-Alajbeg I, Milenovic A, Balija M (2012) Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer. Med Oral Patol Oral Cir Bucal 17: 10-15
11. Jablonska E, Piotrowski L, Grabowska Z (1997) Serum levels of IL-1β, IL-6, TNF-α, sTNF-RI and CRP in patients with oral cavity cancer. Pathol Oncol Res 3: 126-129